“Bioinformatics and Experimental Study Identifies Two Low-Grade Glioma Subtypes with Distinct Immune Characteristics, Prognosis, and Treatment Responses, and Constructs a Phagocytosis-Related Prognostic Signature”

https://pubmed.ncbi.nlm.nih.gov/38112449

This study used bioinformatics analyses and experimental validation to identify two subtypes of low-grade glioma (LGG) with distinct immune characteristics, prognosis, and responses to immunotherapy and targeted drugs, and constructed a phagocytosis-related prognostic signature to estimate the risk level of each LGG sample.